
Antiverse is an artificial intelligence-driven techbio company that specializes in antibody design against challenging targets, including G-protein coupled receptors and ion channels. Headquartered in Cardiff, UK, and with offices in Boston, MA, Antiverse combines state-of-the-art machine learning techniques and advanced cell line engineering to develop de novo antibody therapeutics. The company has collaborated with three top global pharmaceutical companies and is developing a strong internal pipeline of antibodies against several challenging drug targets across various indications.

Antiverse is an artificial intelligence-driven techbio company that specializes in antibody design against challenging targets, including G-protein coupled receptors and ion channels. Headquartered in Cardiff, UK, and with offices in Boston, MA, Antiverse combines state-of-the-art machine learning techniques and advanced cell line engineering to develop de novo antibody therapeutics. The company has collaborated with three top global pharmaceutical companies and is developing a strong internal pipeline of antibodies against several challenging drug targets across various indications.